Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes

被引:84
|
作者
Shalhub, Sherene [1 ]
Black, James H., III [2 ]
Cecchi, Alana C. [3 ]
Xu, Zhi [4 ]
Griswold, Ben F. [4 ]
Safi, Hazim J. [5 ]
Milewicz, Dianna M. [3 ]
McDonnell, Nazli B. [4 ]
机构
[1] Univ Washington, Dept Gen Surg, Div Vasc Surg, Seattle, WA 98195 USA
[2] Johns Hopkins Univ Hosp, Dept Surg, Div Vasc Surg & Endovasc Therapy, Baltimore, MD 21287 USA
[3] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Med Genet, Houston, TX 77030 USA
[4] NIA, Baltimore, MD 21224 USA
[5] Univ Texas Med Sch Houston, Dept Cardiothorac & Vasc Surg, Houston, TX USA
关键词
SYNDROME TYPE-IV; COL3A1; GENE; MUTATIONS; MANAGEMENT; CELIPROLOL;
D O I
10.1016/j.jvs.2014.01.070
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The management of arterial pathology in individuals with vascular Ehlers-Danlos syndrome (vEDS) remains a challenge. Here we describe the correlation between COL3A1 gene mutation type and the clinical phenotype in individuals with vEDS. Methods: Individuals with confirmed molecular diagnoses of vEDS were enrolled in a multi-institutional natural history study. Data collected included demographics, clinical and family histories, arterial pathology (aneurysm, dissection, and rupture), operative details, and autopsy reports. Individuals were classified into two cohorts by the type of COL3A1 mutations and their effect on the amount of normal collagen produced: those with mutations that lead to minimal (MIN) production (10%-15%) of normal type III collagen and those with haploinsufficiency (HI) mutations that lead to production of 50% of the normal type III collagen. Results: A cohort of 68 individuals (72%) from 56 families had arterial pathology (44% male) with 13% HI. The HI group was older at the time of their first vascular event (mean, 42 [range, 26-58] years vs 33 [range, 8-62] years; P = .016) and had a higher incidence of aortic pathology than the MIN group (56% vs 21%; P = .025). Visceral arterial pathology was seen in 43 arteries in 23 individuals in the MIN group vs only one artery in five individuals in the HI group. Emergency surgical procedures were more likely to be undertaken when vEDS diagnosis was not known (81% vs 41%; P = .005), and 81% of these procedures were open surgical repair compared with 19% endovascular repairs (P = .019). Open and endovascular repairs were equally used in the elective setting. Postoperative complications were highest when the diagnosis of vEDS was not known (62% vs 14%; P < .001) and when procedures were undertaken in an emergency setting (5% vs 55% P < .001). Mortality due to arterial complications was 0% in the HI cohort and 21% in the MIN cohort (P = .132). Conclusions: Arterial pathology in vEDS individuals is related to the underlying COL3A1 mutation type. The arterial pathology in individuals with HI mutations occurs at later ages with a higher incidence of aortic disease compared with other COL3A1 mutation types. Molecular diagnosis is recommended because diagnosis confirmation, appropriate surveillance, and prophylactic interventions in an elective setting improve surgical outcomes.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [1] Arterial complications of vascular Ehlers-Danlos syndrome
    Eagleton, Matthew J.
    JOURNAL OF VASCULAR SURGERY, 2016, 64 (06) : 1869 - 1880
  • [2] Vascular Ehlers-Danlos syndrome and pregnancy: A systematic review
    Haem, Theo
    Benson, Betty
    Dernoncourt, Amandine
    Gondry, Jean
    Schmidt, Jean
    Foulon, Arthur
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 (12) : 1620 - 1629
  • [3] Evaluating perinatal and neonatal outcomes among children with vascular Ehlers-Danlos syndrome
    Stephens, Sara B.
    Russo, Melissa
    Shalhub, Sherene
    Beecroft, Taylor
    Weigand, Justin
    Milewicz, Dianna M.
    Morris, Shaine A.
    GENETICS IN MEDICINE, 2022, 24 (10) : 2134 - 2143
  • [4] A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis
    Shalhub, Sherene
    Byers, Peter H.
    Hicks, Kelli L.
    Coleman, Dawn M.
    Davis, Frank M.
    De Caridi, Giovanni
    Weaver, K. Nicole
    Miller, Erin M.
    Schermerhorn, Marc L.
    Shean, Katie
    Oderich, Gustavo
    Ribeiro, Mauricio
    Nishikawa, Cole
    Charlton-Ouw, Kristofer
    Behrendt, Christian-Alexander
    Debus, E. Sebastian
    von Kodolitsch, Yskert
    Zarkowsky, Devin
    Powell, Richard J.
    Pepin, Melanie
    Milewicz, Dianna M.
    Regalado, Ellen S.
    Lawrence, Peter F.
    Woo, Karen
    JOURNAL OF VASCULAR SURGERY, 2020, 71 (01) : 149 - 157
  • [5] Ultrastructural scoring of skin biopsies for diagnosis of vascular Ehlers-Danlos syndrome
    Kim-Thanh Ong
    Plauchu, Henri
    Peyrol, Simone
    Roux, Elisabeth
    Errazuriz, Elisabeth
    Van Kien, Philippe Khau
    Arbeille, Brigitte
    Gaulier, Alain
    Georgescou, Gabriela
    Collignon, Patrick
    Germain, Dominique P.
    Gaveau, Marie-Noelle
    Perdu, Jerome
    Laurent, Stephane
    Bruneval, Patrick
    Boutouyrie, Pierre
    VIRCHOWS ARCHIV, 2012, 460 (06) : 637 - 649
  • [6] Assessment of arterial damage in vascular Ehlers-Danlos syndrome: A retrospective multicentric cohort
    Adham, Salma
    Legrand, Anne
    Bruno, Rosa-Maria
    Billon, Clarisse
    Dalens, Violaine
    Boutouyrie, Pierre
    Mazzella, Jean-Michael
    Gueguen, Sonia
    Frank, Michael
    Mirault, Tristan
    Jeunemaitre, Xavier
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome
    Byers, Peter H.
    Belmont, John
    Black, James
    De Backer, Julie
    Frank, Michael
    Jeunemaitre, Xavier
    Johnson, Diana
    Pepin, Melanie
    Robert, Leema
    Sanders, Lynn
    Wheeldon, Nigel
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2017, 175 (01) : 40 - 47
  • [8] The Ehlers-Danlos Syndrome
    Malfait, Fransiska
    De Paepe, Anne
    PROGRESS IN HERITABLE SOFT CONNECTIVE TISSUE DISEASES, 2014, 802 : 129 - 143
  • [9] A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome
    Shalhub, Sherene
    Byers, Peter H.
    Hicks, Kelli L.
    Charlton-Ouw, Kristofer
    Zarkowsky, Devin
    Coleman, Dawn M.
    Davis, Frank M.
    Regalado, Ellen S.
    De Caridi, Giovanni
    Weaver, K. Nicole
    Miller, Erin M.
    Schermerhorn, Marc L.
    Shean, Katie
    Oderich, Gustavo
    Ribeiro, Mauricio
    Nishikawa, Cole
    Behrendt, Christian-Alexander
    Debus, E. Sebastian
    von Kodolitsch, Yskert
    Powell, Richard J.
    Pepin, Melanie
    Milewicz, Dianna M.
    Lawrence, Peter F.
    Woo, Karen
    JOURNAL OF VASCULAR SURGERY, 2019, 70 (05) : 1543 - 1554
  • [10] An old drug for a rare disease: The example of celiprolol for vascular Ehlers-Danlos syndrome
    Boutouyrie, Pierre
    THERAPIE, 2020, 75 (02): : 175 - 181